Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Effects of Semaglutide on CKD Outcomes: A Post Hoc Pooled Analysis from the SUSTAIN 6 and PIONEER 6 Trials

    Journal of the American Society of Nephrology Date published:

  • Reduction in the Rate of eGFR Decline with Semaglutide vs. Placebo: A Post Hoc Pooled Analysis of SUSTAIN 6 and PIONEER 6

    Journal of the American Society of Nephrology Date published:

  • The Effects of Allopurinol on the Progression of CKD According to Baseline Serum Urate Level: Results from Post Hoc Analyses of the CKD-FIX Trial

    Journal of the American Society of Nephrology Date published:

  • The Effects of Allopurinol on the Progression of CKD According to Baseline Kidney Function: Prespecified Analyses of the CKD-FIX Trial

    Journal of the American Society of Nephrology Date published:

  • International consensus definitions of clinical trial outcomes for kidney failure: 2020

    Kidney International Date published:

  • Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A PostHoc Analysis from the CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories

    Clinical Journal of the American Society of Nephrology Date published:

  • Haemodialysis duration, frequency and intensity for end-stage kidney disease

    Cochrane Database of Systematic Reviews Date published:

  • Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes

    Kidney International Date published:

  • A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)

    Journal of the American Society of Nephrology Date published:

  • The impact of the COVID -19 pandemic on medical education

    Medical Journal of Australia Date published:

  • Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program

    Clinical Kidney Journal Date published:

  • Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program

    Diabetes, Obesity and Metabolism Date published:

  • Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program

    Journal of the American Society of Nephrology Date published:

  • The impact of the COVID -19 pandemic on medical education

    Medical Journal of Australia Date published:

  • Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis

    Clinical Journal of the American Society of Nephrology Date published: